Agenus
AGEN
#8503
Rank
โ‚ฌ0.25 B
Marketcap
6,02ย โ‚ฌ
Share price
-7.08%
Change (1 day)
46.08%
Change (1 year)

Revenue for Agenus (AGEN)

Revenue in 2026 (TTM): โ‚ฌ0.10 Billion

According to Agenus 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.10 Billion. In 2025 the company made a revenue of โ‚ฌ97.21 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ99.42 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agenus from 2000 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.10 B8.86%
2025 โ‚ฌ97.21 M-2.23%
2024 โ‚ฌ99.42 M-29.69%
2023 โ‚ฌ0.14 B54.73%
2022 โ‚ฌ91.38 M-65%
2021 โ‚ฌ0.26 B264.2%
2020 โ‚ฌ71.68 M-46.48%
2019 โ‚ฌ0.13 B316.57%
2018 โ‚ฌ32.15 M-10.02%
2017 โ‚ฌ35.73 M66.52%
2016 โ‚ฌ21.46 M-5.45%
2015 โ‚ฌ22.69 M295.62%
2014 โ‚ฌ5.73 M160.18%
2013 โ‚ฌ2.2 M-81.73%
2012 โ‚ฌ12.06 M468.61%
2011 โ‚ฌ2.12 M-15.99%
2010 โ‚ฌ2.52 M8.53%
2009 โ‚ฌ2.32 M22.73%
2008 โ‚ฌ1.89 M-50.13%
2007 โ‚ฌ3.8 M624.95%
2006 โ‚ฌ0.52 M-1.37%
2005 โ‚ฌ0.53 M2.03%
2004 โ‚ฌ0.52 M-81.4%
2003 โ‚ฌ2.8 M-14.14%
2002 โ‚ฌ3.26 M-36.73%
2001 โ‚ฌ5.15 M997.72%
2000 โ‚ฌ0.46 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ83.34 B 77,695.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ56.88 B 52,996.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.93 B 39,041.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ38.19 B 35,555.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ0.74 M-99.30%๐Ÿ‡บ๐Ÿ‡ธ USA